Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 1-7 of 7 (Search time: 0.003 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2016The glucagon-like peptide 1 receptor agonist exenatide inhibits small intestinal motility, flow, transit, and absorption of glucose in healthy subjects and patients with type 2 diabetes: a randomized controlled trialThazhath, S.; Marathe, C.; Wu, T.; Chang, J.; Khoo, J.; Kuo, P.; Checklin, H.; Bound, M.; Rigda, R.; Crouch, B.; Jones, K.; Horowitz, M.; Rayner, C.
2017Acute effects of the glucagon-like peptide-1 receptor agonist, exenatide, on blood pressure and heart rate responses to intraduodenal glucose infusion in type 2 diabetesThazhath, S.; Marathe, C.; Wu, T.; Chang, J.; Khoo, J.; Kuo, P.; Checklin, H.; Bound, M.; Rigda, R.; Horowitz, M.; Jones, K.; Rayner, C.
2017Relationships of the early insulin secretory response and oral disposition index with gastric emptying in subjects with normal glucose toleranceMarathe, C.; Rayner, C.; Lange, K.; Bound, M.; Wishart, J.; Jones, K.; Kahn, S.; Horowitz, M.
2015Relationships of early and late glycemic responses with gastric emptying during an oral glucose tolerance testMarathe, C.; Horowitz, M.; Trahair, L.; Wishart, J.; Bound, M.; Lange, K.; Rayner, C.; Jones, K.
2014Small intestinal glucose exposure determines the magnitude of the incretin effect in health and type 2 diabetesMarathe, C.; Rayner, C.; Bound, M.; Checklin, H.; Standfield, S.; Wishart, J.; Lange, K.; Jones, K.; Horowitz, M.
2015Comparative effect of intraduodenal and intrajejunal glucose infusion on the gut-incretin axis response in healthy malesWu, T.; Thazhath, S.; Marathe, C.; Bound, M.; Jones, K.; Horowitz, M.; Rayner, C.
2016Effect of duodenal glucose load on blood pressure in type 2 diabetesMarathe, C.; Horowitz, M.; Trahair, L.; Bound, M.; Checklin, H.; Lange, K.; Rayner, C.; Jones, K.